Athough more than 90% of syphilis cases are diagnosed in developing countries, syphilis rates in industrialized countries have been increasing since the 1980s. Untreated syphilis in pregnancy is associated with high rates of adverse pregnancy outcomes, including fetal loss, premature birth, congenital syphilis, and neonatal death. We reviewed the recent literature on adverse pregnancy outcomes associated with untreated syphilis and the benefits of early and effective treatment.
INTRODUCTION
Syphilis is a sexually transmitted disease and, if left untreated, is associated with a high case fatality rate of up to 60% along with serious long-term complications among survivors. Syphilis has been called the 'great imitator' because it has so many symptoms which can often mimic other infectious and noninfectious diseases ( Table 1 ). During the 18th and 19th centuries, syphilis was very common in Europe, but declined rapidly with widespread use of antibiotics in the early 20th century. Most cases of syphilis are now diagnosed in low and middleincome countries, where 90% of the estimated 12 million cases occur [1] . In the United Kingdom and other industrialized countries, however, syphilis rates have been increasing in men and women since the 1980s, particularly among intravenous drug users, HIV-infected individuals, and MSM [2] . Increased rates among heterosexuals have also been reported since the 1990s, especially in Eastern Europe and Asia, and have been attributed to unsafe sexual practices, such as sexual promiscuity, prostitution, and decreasing use of barrier protection.
TRANSMISSION
Syphilis is caused by a spiral-shaped, highly mobile spirochaete, Treponema pallidum, which is transmitted by direct contact with a syphilis sore during vaginal, anal, or oral sex. The spirochaete is able to pass through intact mucous membranes (mouth, vagina, and rectum) or compromised skin. Around 30-60% of those exposed to primary or secondary syphilis will get the disease; inoculation with only 57 organisms results in a 50% chance of being infected. Sores can be found on the penis, vagina, anus, rectum, lips, and mouth. The infection can also be transmitted from mother to fetus during pregnancy or childbirth (congenital syphilis). Humans are the only known natural reservoir. T. pallidum has a slow doubling time of more than 30 h, which explains the chronic nature of the infection.
SYPHILIS IN PREGNANCY
Syphilis in pregnancy is not rare. Globally, far more pregnant women have syphilis than HIV infection: 1.9 million (in 2008) and 1.5 million (2010), respectively, mostly in developing countries [1] . The proportion of pregnant women with syphilis who are diagnosed and treated during pregnancy is unknown, but estimates suggest that it is less than 10%. The risk of transplacental infection of the fetus is 60-80%, and the likelihood of infection is increased during the second half of pregnancy. Mother-to-child transmission is higher in untreated maternal primary or secondary syphilis (60-90%), decreasing to 40% in early latent syphilis, and less than 10% in late latent syphilis. This compares with 20% mother-to-child in-utero transmission rate for HIV. In sub-Saharan Africa, syphilis contributes to 20% of perinatal deaths. Two-thirds of syphilitic infants are asymptomatic at birth and the infection may remain clinically silent throughout their
KEY POINTS
In the United Kingdom and other industrialized countries, syphilis rates have been increasing in men and women since the 1980s.
Untreated syphilis in pregnancy has a high rate of transplacental transmission, with a 66.5% risk of adverse pregnancy outcomes compared with a background rate of 14.3%.
Diagnosis and treatment of syphilis in the first and second trimesters of pregnancy significantly reduces the risk of adverse pregnancy outcomes back to baseline rates. Table 1 . Characteristics of the different stages of syphilis infection
Primary stage
The primary stage typically presents with a single chancre (a firm, round, painless, nonitchy skin ulceration) usually at the site of infection and must be treated with appropriate antibiotics to prevent progression to later stages. A chancre can last for 3-6 weeks regardless of whether it is treated, but can be missed because it is painless
Secondary stage
The secondary stage occurs 4-10 weeks after primary infection and is characterized by a diffuse symmetrical, reddishpink, nonitchy rash on the trunk and extremities, frequently involving the palms of the hand and soles of the feet. The rash may become macular, papular or pustular, and may affect the mucous membrane, where it may form flat, broad, whitish, wart-like lesions known as condyloma lata. Other symptoms include fever, sore throat, weight loss, hair loss, and headache. Rarely, secondary syphilis may also be associated with inflammation of the liver, kidney, bone and joints, nerves and eyes. Symptoms of secondary syphilis usually resolve after 3-6 weeks, although they may recur in up to a quarter. Around 25-50% of patients diagnosed with secondary syphilis do not report previously having had the classic chancre of primary syphilis
Latent stages
The latent phase is usually asymptomatic, with disappearance of all the primary and secondary symptoms. If left untreated, the latent phase can last anywhere between 3 and 30 years, but can be diagnosed by a blood test confirming serological evidence of disease Tertiary stage Around a third of untreated syphilis cases will go on to develop tertiary syphilis, which can be divided into three different forms:
Gummatous syphilis usually occurs 15 years after the initial infection, but can occur up to 50 years later. This stage is characterized by the formation of chronic gummas, which are soft, noncancerous inflammatory lesions with a firm necrotic centre. Gummata occur most often in the liver, but can also occur in the bone, brain, heart, skin, testis, and eyes Neurosyphilis affects the central nervous system and can occur early (asymptomatic or syphilitic meningitis) or late (meningo-vascular syphilis, general paresis, tabes dorsalis). Late neurosyphilis typically occurs 4-25 years after the initial infection. Meningovascular syphilis is characterized by seizures. General paresis in late syphilis results from inflammation in the brain, causing progressive dementia, and paralysis. Tabes dorsalis (slow degeneration of the nerves primarily in the spinal cord) causes a range of symptoms, including weakness, diminished reflexes, intense shooting and burning pains, pricking sensations, joint damage and degeneration, loss of coordination, personality changes, urinary incontinence, dementia, deafness, and visual impairment. Neurosyphilis is diagnosed by lumbar puncture showing high white cell (predominately lymphocytes) and protein levels in the cerebrospinal fluid in patients with known syphilis infection Cardiovascular syphilis usually occurs 10-30 years after the initial infection and the most common complication is inflammation of the aorta (aortitis) which may result in formation of an aneurysm lifetime. In infants, manifestations of syphilis are classified as early congenital (birth to 2 years) and late congenital (after 2 years). Early congenital syphilis commonly manifests during the first 3 months of life with hepatosplenomegaly (70%), rash (70%), fever (40%), neurosyphilis (20%), pneumonitis (20%), and generalized lymphadenopathy. The rash may manifest as vesicular, bullous, or a macular copper-coloured rash on the palms and soles with papules around the nose, mouth, and diaper area, as well as petechial lesions. The infant may fail to thrive and have a characteristic muco-purulent or blood-stained nasal discharge causing snuffles. A few infants develop meningitis, with complications such as choroiditis, hydrocephalus, or seizures, with consequent long-term neurodevelopmental sequelae. In the first year of life, damage to the long bones and ribs can cause characteristic radiological changes with limb pseudoparalysis.
Late congenital syphilis typically manifests after 2 years of life if the early congenital infection is not appropriately treated. Late congenital syphilis is characterized by gummatous ulcers on the nose, nasal septum, hard palate, and around the bones, resulting in saber shins (sharp forward bowing of the tibia) and bossing of the frontal and parietal bones of the skull. Neurosyphilis is usually asymptomatic, but paresis and tabes dorsalis may develop in adolescence. Damage to the optic nerve can lead to recurrent interstitial keratitis (inflammation of the cornea), often resulting in permanent scarring, and blindness. Progressive sensorineural deafness may appear at any age and can be irreversible. Infrequently, malformations of the teeth and jaw bones result in the characteristic 'Hutchinson' incisors, 'mulberry molars', rhagades (fissures, cracks, or linear scars at the angles of the mouth and nose) and 'bulldog' facies.
RISK OF ADVERSE PREGNANCY OUTCOMES
Adverse pregnancy outcomes of syphilis include fetal loss or stillbirth and, in liveborn infants, premature birth, low birthweight, congenital syphilis, or neonatal death. A recent systematic review identified 3258 publications and included six large case-control studies which, together, showed that 66.5% of pregnant women with untreated syphilis had adverse pregnancy outcomes compared with 14.3% in pregnant women without syphilis [3 & ]. Fetal loss and stillbirth were 21% more frequent, neonatal deaths 9% and prematurity or low birthweight 6% more frequent than among pregnant women without syphilis. Additionally, 15% of infants had clinical evidence of congenital syphilis and there was a 10% higher risk of death compared with infants born to uninfected mothers. In a large Tanzanian study, 94% of stillbirths and 77% of any adverse pregnancy outcomes in women with untreated syphilis were attributed to the infection and, among live-births to women with untreated syphilis, the infection accounted for 70% of low birthweight and 84% of premature infants [4] . Notably, women with untreated syphilis were six times more likely to deliver prematurely than uninfected pregnant women.
In 2008, it was estimated that around 521 000 adverse pregnancy outcomes were associated with maternal syphilis globally, including 212 000 stillbirths or early fetal deaths, 92 000 neonatal deaths, 65 000 preterm or low birthweight infants, and 152 000 infected newborns [5] . The high rate of adverse pregnancy outcomes is probably because of direct damage caused by T. pallidum to both the placenta (microvascular proliferation and inflammation) and the umbilical cord -both of which will compromise fetal growth and viability.
EARLY DETECTION AND TREATMENT IN PREGNANCY
Early detection and treatment of syphilis in pregnancy can significantly reduce adverse pregnancy outcomes, including stillbirths, perinatal deaths, and congenital syphilis [6] . An analysis of 25 published studies assessing effectiveness of interventions to screen and manage infections during pregnancy found that those focusing on syphilis showed a significant 80% reduction in stillbirths than strategies to treat, detect, and/or prevent malaria (22% reduction) HIV (7% reduction) or bacterial vaginosis (12% reduction) [7] . In Tanzania, treatment of 133 pregnant women with active syphilis and high antibody titres (and therefore, high risk of transplacental transmission) and 249 women with low-titre syphilis with a single dose of benzathine penicillin reduced adverse birth outcomes (stillbirth, low birthweight, and premature births) to background rates, as assessed through follow-up of 950 uninfected women [8] .
In China, where 500 000 pregnant women were screened and 1855 women were identified and treated for syphilis during 2002-2005, the rate of mother-to-child transmission was significantly reduced from 54/100 000 to 22/100 000 [9] . The authors noted that nearly all of the reduction was observed in women who were treated before the third trimester (28 weeks); the infants of women who first sought antenatal care in the third trimester or at delivery had often already developed congenital syphilis.
TIMING OF DETECTION AND TREATMENT
A recent systematic review identified 1199 studies, selected 84 for further review and included five studies to assess the optimal timing of antenatal interventions to prevent mother-to-child transmission of syphilis and associated adverse outcomes [10] . All of the studies showed a lower prevalence of adverse outcomes among women who received an intervention (that included screening and treatment) in the first and second trimesters compared with the third trimester. Adverse outcomes were 2.2 times more common in women treated in the third trimester compared with treatment in the first or second trimester. There was also a 2.1-fold higher risk of prematurity in mothers presenting late to the antenatal clinic.
INVESTIGATIONS
The diagnosis of syphilis can be confirmed by direct visual inspection using microscopy or by diagnostic blood tests (Table 2 ) [11] . These tests, however, cannot distinguish between different disease stages. In early congenital syphilis, the diagnosis is usually suspected because of maternal disease. At birth, the neonate should have a thorough clinical examination, with darkfield microscopy (where available) of the placenta, umbilical cord and any skin/ mucosal lesions, as well as a quantitative nontreponemal serum test [rapid plasma reagin (RPR)/venereal disease research laboratory (VDRL)]; testing cord blood is less sensitive and less specific. Those with clinical disease or suggestive serological test results should have additional blood tests (full blood counts, liver function tests, inflammatory markers), lumbar puncture (cell count, VDRL, protein), longbone radiographs, and other investigations as clinically indicated (ophthalmological review, hearing tests, radiographs, neuroimaging). Diagnosis can be confirmed by microscopic visualization of spirochetes. Neonatal serology is complicated by the presence of transplacentally-acquired maternal IgG antibodies. However, a neonatal nontreponemal antibody titre more than four times the maternal titre would support active infection because such a high ratio is unlikely to be achieved through passive transfer.
As maternal disease acquired late in pregnancy may be transmitted before development of antibodies, syphilis should be considered in any newborn with typical clinical manifestations even with low titres. Fluorescent antibody assays for antitreponemal IgM, which is not transferred across the placenta, have sometimes been used to confirm neonatal disease. Because nontreponemal tests can yield false-positive results, they should be confirmed with a specific treponemal test. However, any additional testing should not delay treatment in a high-risk or symptomatic infant.
Late congenital syphilis can be diagnosed by the clinical history, distinctive physical signs, and serology. The Hutchinson triad of interstitial keratitis, Hutchinson incisors, and eighth cranial nerve deafness is diagnostic. Sometimes the nontreponemal test may be negative, but the fluorescent treponemal antibody absorption test should be positive. Syphilis should be considered in any infant with unexplained deafness, progressive intellectual deterioration, or keratitis.
TREATMENT
The treatment of early and late syphilis, and of syphilis diagnosed in pregnancy, is summarized in Table 3 . Infants with confirmed or highly probable early congenital syphilis should receive aqueous crystalline penicillin G 50 000 units/kg i.v. twice daily for the first 7 days and 8-hourly thereafter for a total of 10 days, or procaine penicillin G 50 000 units/kg intramuscularly once/day for 10 days. If at least 1 day of therapy is missed, the entire course must be repeated. This regimen is also recommended for infants with possible syphilis if the mother fulfils any of the following criteria: untreated; unknown treatment status; treated 4 weeks or less before delivery; inadequately treated (e.g. nonpenicillin regimen); or maternal evidence of relapse or reinfection ( four-fold increase in maternal titres).
In infants with possible syphilis (e.g. whose mothers were not adequately treated) but who are clinically well and have a completely negative evaluation, a single dose of intramuscular benzathine penicillin 50 000 units/kg is an alternative treatment option, but only if follow-up is assured, with nontreponemal serological testing monthly for the first 3 months and then at 6 months; treatment would then be initiated if the antibody titres rise or become positive at 6 months.
When congenital syphilis is diagnosed in older infants and children, other family members should be assessed for physical and serological evidence of infection. In the index case, a lumbar puncture should be performed before initiating treatment (aqueous crystalline penicillin G 50 000 units/kg i.v. every 4-6 h for 10 days). A single dose of intramuscular benzathine penicillin G 50 000 units/kg may also be given at the end of treatment. Alternatively, if a full evaluation is completely negative and the child is asymptomatic, intramuscular benzathine penicillin G 50 000 units/kg once a week for 3 weeks may be offered. Many patients do not become seronegative but do have a four-fold decrease in reagin antibody titres (e.g. VDRL). Patients should be re-evaluated at regular intervals to ensure appropriate serological response to therapy and early identification of any relapse.
Interstitial keratitis is usually treated by ophthalmologists with corticosteroid and atropine drops. There is some, albeit limited, evidence to treat patients with sensorineural hearing loss with penicillin with a corticosteroid such as oral prednisone 0.5 mg/kg once daily for 1 week, followed by 0.3 mg/kg once daily for 4 weeks, with gradual weaning over 2-3 months [12, 13] . Response to treatment may be less effective in patients with congenital syphilis and those with profound deafness [14] . A recent, small case-series reported improved hearing and audiogram results in nine (47%) and seven (37%) of 19 patients with otosyphilis following a 21-day oral course of 400 mg/day doxycycline [15] .
FOLLOW-UP TESTING
Seropositive infants and those whose mothers were seropositive should have VDRL or RPR titres every 2-3 months until the test is nonreactive or the antibody titre has decreased four-fold. In uninfected and in successfully-treated infants, nontreponemal antibody titres are usually nonreactive by 6 months of age. Passively acquired syphilis antibodies may be 
PREVENTION
There is currently no vaccine available for prevention; the difficulties and obstacles in developing an effective vaccine against syphilis have been reviewed recently [16 && ]. Abstinence from intimate physical contact with an infected person will reduce syphilis transmission, as will proper use of a latex condom. Congenital syphilis can be prevented by screening and treating mothers during early pregnancy. Universal antenatal screening is recommended in most industrialized countries, and the WHO recommends all women be tested at their first antenatal visit and again in the third trimester. If they are positive, they recommend their partners also be screened and treated.
In the United Kingdom, antenatal screening for syphilis is a well established component of the Infectious Diseases in Pregnancy Screening Programme, which includes hepatitis B, HIV, syphilis and rubella. The UK-recommended screening includes a highly sensitive enzyme immunoassay to detect antibodies, followed by confirmatory treponemal test (T. pallidum particle agglutination assay/T. pallidum hemagglutination assay). The reported sensitivity and specificity of treponemal enzyme immunoassays is high, ranging from 85 to 99.5% and from 98.3 to 100%, respectively. Uptake of antenatal screening for syphilis in early pregnancy has consistently been high (>95%). During 2005-2012, of the 524 000-710 000 women screened, 0.15% (range 0.14-1.17%, equivalent to 834-1171 women annually) were initially screened positive for syphilis but less than a third of them had an active infection that required treatment [17] . The rest were subsequently identified as having evidence of resolved or treated syphilis. The incidence of congenital syphilis in a UK national surveillance study was 1.4/100 000 live-births and still-births in 2010 and 0.25/100 000 in 2011 [18] . Cases were mainly of white ethnicity and the influence of the eastern European syphilis epidemic was observed. Cases were generally identified in mothers who were unable to access healthcare service because of cultural barriers or chaotic lifestyles, and who experienced high levels of socioeconomic deprivation. Consequently, these mothers generally accessed clinical services around the time of delivery [19] .
CONCLUSION
Congenital syphilis is still very common in the developing world, as many women do not receive antenatal care or the antenatal care package does not include syphilis screening. In industrialized countries, congenital syphilis is rare but still occurs because those most likely to acquire syphilis are least likely to seek antenatal care. Transplacental transmission of syphilis, especially in the third trimester, is associated with a high rate of adverse outcomes, but the risks can be significantly reduced with early diagnosis (e.g. through antenatal screening) and treatment in the first and second trimester, with careful management of the infant after birth.
